Alpha-1 Antitrypsin Deficiency: Lung and Liver Signs

Alpha-1 Antitrypsin Deficiency: Lung and Liver Signs

This page is educational and is not medical advice. It walks through what usually sits behind breathlessness and liver enzyme changes in adults, which blood markers help sort one possibility from another, and what the alpha-1 antitrypsin test actually measures.

What usually causes this?

Breathlessness and mildly raised liver enzymes have a long list of everyday explanations, and most of them are not genetic findings at all. The useful starting point is the ordinary stuff, because that is where the pattern often fits.

Inhaled irritants matter most for the lungs. Cigarette smoke, vaping, wood smoke, dust at work and heavy air pollution all irritate the airways and reduce how comfortably you move air. Breathlessness that tracks with exposure, or that improves on holiday and worsens at work, is a strong hint in that direction.

Training load and conditioning explain a surprising amount. Going from sedentary to three hard sessions a week leaves you short of breath long before anything is wrong, and a layoff of a few months does the same in reverse. Hard eccentric work, a first marathon or a heavy lifting block can also push liver enzymes up for days afterwards, because some of the same enzymes sit inside skeletal muscle.

Sleep and stress change how breathing feels. Short sleep, disrupted sleep and high stress raise resting heart rate and breathing rate, and air hunger is a common physical feature of anxiety. Snoring with daytime sleepiness is a reason to ask about sleep tests rather than assuming the lungs are at fault.

Alcohol is one of the usual reasons liver markers drift. Regular drinking, a heavy weekend or a stretch of social events can lift enzymes without any lasting change in the liver. Diet and body composition play a role too, because fat stored inside liver cells is one of the ordinary reasons enzymes sit above the range printed on a report.

Recent infection also counts. Chest infections leave a cough and reduced exercise tolerance for weeks, and some viral illnesses nudge liver enzymes for a while afterwards. Some medicines affect liver enzymes as well, so ask your prescriber about anything you take regularly before assuming the number means something else.

Life stage sits underneath all of it. Weight change, falling activity, iron status and the gradual loss of lung elasticity with age all shift how breathing feels year to year.

An inherited cause belongs on the list when the pattern does not fit. Research suggests that alpha-1 antitrypsin deficiency is frequently recognised late, long after lung symptoms begin 1. Studies indicate that the protein is produced mainly in the liver and protects lung tissue from neutrophil elastase, an enzyme released by white blood cells 2. Smoking is associated with earlier and more severe lung disease in people carrying the deficiency variants 3. Breathlessness or emphysema appearing at a younger age than expected, especially with little or no smoking history, is one of the situations where clinicians think about testing.

Which blood tests can help explain it?

Three routine liver enzymes carry most of the early signal, and the alpha-1 antitrypsin level itself is a separate, specific blood test. The enzymes do not identify a cause on their own. They tell a clinician whether the liver deserves a closer look, and they give a baseline to repeat.

Marker Why it is linked to this symptom What a result can and cannot tell you
ALT ALT sits largely inside liver cells and leaks into the blood when those cells are under strain. In alpha-1 antitrypsin deficiency the abnormal protein builds up inside liver cells rather than leaving them, so ALT is one of the first numbers reviewed. A raised ALT flags liver strain worth investigating. It does not name a cause, and a result inside the range printed on your report does not rule liver change out.
AST AST is found in liver cells and also in skeletal muscle and heart muscle. Looked at next to ALT, it helps a clinician judge whether a rise is coming from the liver or from somewhere else. The ALT and AST pattern narrows the possibilities. It cannot separate an inherited cause from alcohol, body composition or recent hard training without more information.
GGT GGT rises when bile flow is restricted and with regular alcohol intake, so it helps separate one kind of liver pattern from another. GGT adds context to ALT and AST. On its own it is a non-specific marker and never identifies a condition.

Compare each number against the range printed on your own lab report, because reference ranges vary by laboratory, age and sex. Trends across repeat tests usually say more than a single reading.

Can a raised ALT point to liver strain?

Yes, a raised ALT is one of the clearest early signals that liver cells are under strain, although it never names the reason. ALT is concentrated inside liver cells, so when those cells are irritated or injured, more of the enzyme appears in the bloodstream.

The link to this particular inherited condition is structural. The abnormal version of the protein folds incorrectly and is retained inside liver cells instead of being released into the blood, and that retention is what places a load on the liver 4. Research suggests that liver involvement in affected adults covers a wide range, from enzyme changes with no symptoms through to fibrosis and cirrhosis 5.

Plenty of ordinary things move ALT too. Alcohol in the days before a draw, fat stored in the liver, a recent viral illness, a hard training block and some medicines can all lift it, so ask your prescriber about anything you take regularly. That is exactly why a single raised ALT is a prompt to look further rather than a conclusion. The observation is a number above the range printed on your report. The meaning is possible liver strain from any of several sources. The next step is a conversation with a clinician about repeating the test and deciding what else to check.

What does AST add to the picture?

AST adds a second angle, because it comes from the liver but also from skeletal and heart muscle, so comparing it with ALT helps a clinician work out where a rise is coming from. A gym session, a long run or a muscle injury can lift AST without the liver being involved at all.

In liver conditions, the balance between the two enzymes and how it behaves over months carries more information than either number alone.

Other things that change AST include heavy alcohol intake, thyroid and muscle conditions, and recent strenuous exercise. If you trained hard in the two or three days before your blood draw, mention it, because it changes how the result should be read.

Why do clinicians check GGT?

GGT is checked because it helps sort one liver pattern from another, particularly when bile flow is restricted or alcohol intake is a factor. GGT is sensitive, which is useful, but it is not specific, which means a raised value points at the liver and bile ducts without saying why.

Used next to ALT and AST, GGT helps a clinician decide whether a rise looks more like cell strain, more like a bile flow problem, or more like a mixed picture. In the context of an inherited deficiency, GGT is one of the markers followed over time as part of watching liver health rather than a test that identifies the condition.

GGT also moves with regular alcohol intake, with fat stored in the liver, with gallbladder and bile duct conditions, and with some medicines, so ask your prescriber before drawing conclusions. A raised GGT with normal ALT and AST means something different from all three rising together, and that distinction is a clinician's call.

How is alpha-1 antitrypsin itself measured, and who gets tested?

The condition is identified with two blood tests used together, one that measures how much alpha-1 antitrypsin is circulating and one that identifies which gene variants a person carries. Research suggests that a low circulating level is the screening step and that confirmation comes from genotype or phenotype testing, because the gene variants determine what the low level means 7.

Both parts can be done from a standard blood sample. The level test is a simple quantitative measurement, read against the range printed on your lab report. The gene test looks for the specific variants that reduce production or produce the abnormal form of the protein, with the Z variant being the one most associated with both lung and liver involvement 3.

Who should be tested is set out in clinical guidance rather than left to guesswork. A clinical practice guideline recommends targeted testing for all adults with chronic obstructive pulmonary disease, and this is one of the clearest situations where testing changes what a clinician does next 8. Testing is also considered in adults with emphysema that appears at a younger age than expected, in adults with persistent airflow obstruction, in people with unexplained liver disease, and in blood relatives of someone already identified 9.

If a result is outside the range printed on your report, that is a reason to speak with a clinician promptly rather than a reason to self-diagnose. Treatment decisions belong to a licensed provider, who weighs the test results against lung function, liver markers, symptoms and family history.

What can a normal panel still miss?

A clean liver panel and a normal-looking protein level can both still miss things, which is why blood work is one input rather than the whole answer. Alpha-1 antitrypsin behaves as an acute phase protein, so a level drawn during infection or inflammation can read higher than it would otherwise, which is one reason a level alone is not treated as the final word 10.

Liver enzymes have their own blind spot. Research suggests that significant liver change can be present in affected adults without obvious symptoms, so enzymes sitting inside the printed range do not prove the liver is unaffected 5. Imaging and other assessments answer questions that enzymes cannot.

Blood tests also say nothing about airflow. How much air you can move, how fast you can move it and how well gas transfers across the lung are measured with breathing tests, not with a blood draw. A panel will not show deconditioning, poor sleep, anxiety-driven breathlessness, vocal cord problems, scarring visible only on imaging or the effect of a workplace exposure. Research suggests that the condition is under-recognised in part because symptoms overlap with far more common lung problems, which is exactly why targeted testing exists 1.

The honest framing is that markers narrow the field. A clinician combines them with your history, your exposures, breathing tests and imaging to reach anything resembling an answer.

When should you see a clinician quickly?

Some signs should never wait for a routine appointment. If you have sudden or severe shortness of breath, chest pain or tightness, coughing up blood, blue or grey lips or fingertips, or new confusion or fainting, call 911 or go to the emergency department.

The same applies to several liver warning signs. If you vomit blood, pass black or tarry stools, develop sudden yellowing of the eyes or skin with fever or abdominal pain, or become drowsy and confused with a swollen abdomen, call 911 or go to the emergency department.

Other changes deserve a prompt appointment rather than an emergency visit. Breathlessness that has been building over months, a cough that will not settle, repeated chest infections, ongoing fatigue, unexplained weight loss, persistent swelling in the legs or a liver result outside the range printed on your report are all worth discussing with a clinician promptly. Bring your results and your family history with you, because a parent or sibling with early lung or liver disease changes how a clinician reads your numbers.

If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.

How can you check these markers?

The FitScript Essential panel measures 40+ biomarkers.

The specific alpha-1 antitrypsin level and gene test are separate, targeted tests that a clinician orders when the history or the enzyme pattern warrants them.

FitScript membership covers 150+ biomarkers tested per year, and Atlas, the AI health advisor, explains what each result means in plain language and how it has moved since your last draw. Atlas does not diagnose. A licensed clinician reviews the picture and decides whether further testing or any treatment is appropriate.

Practical notes help the numbers mean something. Keep the conditions of each draw consistent, note recent hard training or alcohol in the days before, and repeat markers rather than reacting to a single reading. Always discuss your results and any treatment with a clinician or licensed provider before acting on them.

Key takeaways

For more on how the individual liver enzymes are read together and what moves each one, see what do liver function tests show.

References

  1. Alpha(1)-Antitrypsin Deficiency. The New England Journal of Medicine, 2020.
  2. α1-Antitrypsin deficiency. Nature Reviews. Disease Primers, 2016.
  3. Alpha1-antitrypsin deficiency. Lancet, 2005.
  4. Alpha-1-antitrypsin deficiency. Seminars in Liver Disease, 1998.
  5. Presentation and prognosis of liver disease in alpha-1 antitrypsin deficiency. Expert Review of Gastroenterology & Hepatology, 2018.
  6. Alpha-1 antitrypsin deficiency. Medicina Clinica, 2024.
  7. Alpha-1-Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Meta-Analysis and Clinical Practice Guideline. Chest, 2025.
  8. α1-Antitrypsin Deficiency. Clinics in Chest Medicine, 2016.
  9. Alpha1-antitrypsin deficiency: An updated review. Presse Medicale, 2023.

Common questions

What is the alpha 1 antitrypsin test?

The alpha 1 antitrypsin test is a blood test that measures how much of the protein is circulating. A low result suggests the body is making less than expected and points toward a second test that identifies the gene variants involved. A clinician decides whether the test is appropriate and what the numbers mean.

What does AATD stand for?

AATD is the common abbreviation for alpha-1 antitrypsin deficiency, an inherited condition in which the body produces less of a protective protein than usual. It can affect the lungs, the liver or both, and it varies widely between people. Two tests are normally used together. One measures the blood level and the other identifies gene variants.

How does alpha 1 antitrypsin deficiency testing work?

Testing usually starts with a blood sample that measures the protein level. If the level sits below the range printed on your report, a genotype or phenotype test identifies which gene variants are present. A clinician reads those results alongside breathing tests, liver markers and your personal and family history.

Can liver enzymes look normal even when the liver is affected?

Yes. ALT, AST and GGT can sit inside the range printed on your report while the liver is still under strain, so normal numbers do not rule anything out. They are a starting point rather than a final answer, and repeating them over time is usually more informative than one reading.

Who is usually offered testing?

Adults with chronic obstructive lung disease or emphysema, people with unexplained liver enzyme changes, and close blood relatives of someone already identified are the groups usually offered testing. Persistent breathlessness, wheeze or repeated chest infections at a younger age than expected are also reasons to raise it with a clinician.

Does a low protein level mean lung damage has already happened?

No. A low level describes how much protein is circulating, not what has happened inside the lungs or liver. Breathing tests, imaging and liver markers are needed to see whether any organ change exists. Many people with a low level feel well, and a clinician decides what follow-up fits.

Can ALT, AST and GGT alone identify this condition?

No. Those three enzymes show how the liver is coping, not why it is under strain. They can flag something that deserves a closer look, but identifying this inherited condition needs the specific protein level plus a gene test. A clinician chooses which tests to order and in what sequence.

What happens after an abnormal result?

An abnormal result is a prompt for a conversation, not a conclusion. A clinician reviews your history, symptoms and other markers, may repeat the test, and decides whether breathing tests, imaging or a gene test are the sensible next step. Treatment decisions belong to a licensed provider.

Related reading